| Similar Articles |
|---|
 |
The Motley Fool
June 30, 2006
Stephen D. Simpson |
Arrow's Erratic Flight Progress for the med-tech is still slow in coming, though market rewards have come faster. Investors, take note.   |
The Motley Fool
October 6, 2006
Matthew Crews |
Arrow International Keeps on Target Investors, with Arrow's fourth quarter and fiscal 2006 earnings in the bag, now is a good time for a checkup. |
The Motley Fool
September 2, 2005
Stephen D. Simpson |
Can Arrow International Straighten Up? Can the medical products maker overcome capacity constraints and get the top line flying again? Investors, take note. |
The Motley Fool
January 6, 2006
Stephen D. Simpson |
Off Course at Arrow International It's going to take time for the medical device company to add capacity; will customers still be waiting on the other side? Investors, take note. |
The Motley Fool
January 30, 2006
Stephen D. Simpson |
A Bard's Tale The advanced medical technology company's stock already reflects new products' potential. Still, life in the med-tech sector could get more interesting in the coming quarters. Investors, take note. |
The Motley Fool
March 28, 2006
Rich Smith |
Foolish Forecast: Arrow Nocks The medical products maker is having a tough time of things, margins-wise. Investors, do better days lie ahead? |
The Motley Fool
April 21, 2006
Stephen D. Simpson |
Bard Rolls On Nothing flashy here, but at the right price, this would be an interesting med-tech play. Investors, take note. |
The Motley Fool
January 18, 2006
W.D. Crotty |
Another Conglomerate Deconglomerates Tyco's three-way split may be for the best. Confused on where the value is? It appears that investors are, too. |
The Motley Fool
January 25, 2006
Stephen D. Simpson |
Abbott Wins No matter what Boston Scientific does with Guidant, Abbott looks like a winner. This stock might not offer a rocket ride the way smaller biotechs and med-tech companies do, but at today's prices, at least you won't have to worry about a fiery re-entry. |
The Motley Fool
July 17, 2008
Brian Orelli |
Investors Yawn at Abbott Labs' Growth Abbott Labs may be firing on all cylinders, but investors were less than impressed with its earnings release |
The Motley Fool
April 19, 2006
Stephen D. Simpson |
Abbott Gets By Will the acquisition of Guidant's vascular business kick-start this story? Abbott has shown a pretty reliable trend of getting cheap enough to buy at least once a year. Of course, the downside to that is that the stock really hasn't gone anywhere in those seven years. |
The Motley Fool
July 22, 2011 |
Arrow Electronics Earnings Preview Arrow Electronics will unveil its latest earnings on Wednesday. |
PC Magazine
October 10, 2007
Sarah Pike |
Outlook Tip: Better Searching How to do an advanced search in the new Microsoft Outlook. |
The Motley Fool
January 17, 2006
Stephen D. Simpson |
High-Stakes Medical Device Chicken Boston Scientific has upped the ante again. Are they bluffing? Their latest offer is $80 a share -- $42 in cash and $38 in stock. Let's hope the board knows what it is doing, because it is staking the company on this. |
PC Magazine
August 29, 2007
Anton Galang |
Vista Tip: Going Up Vista Windows Explorer gets rid of the back button. |
The Motley Fool
October 19, 2005
Stephen D. Simpson |
Abbott Still a Little Pale Perhaps drug and device pipelines, plus margin improvements, can put some color back into the diversified health-care company's stock. |
The Motley Fool
November 11, 2009
Chris Jones |
Get Over the Gloom and Buy This Stock A lot of people are focusing on the negative aspects of the home security, fire protection, and electronics company, but this analyst is bullish on the stock. |
